Answers are grounded in this paper and cite their sources.
Redox-responsive degradable honeycomb manganese oxide (hMnO2) nanostructures consisting of some lamellar MnO2 platelets were established as a new class of drug carriers for intracellular glutathione-triggered drug release.
No takes yet. Share an insight, caveat, or question.
He et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: